Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122142) titled 'Evaluate the safety, tolerability, pharmacokinetics, and preliminary efficacy Legubicin for Injection in patients with advanced malignant solid tumors' on April 9.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: The East Hospital Affiliated to Tongji University
Condition:
late-stage solid tumor
Recruitment Status: Recruiting
Phase: 1
Date of First Enrollment: 2020-05-07
Target Sample Size: Experimental group:30;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=302691
Published by HT Digital Content Services with permission...